Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Cash from Investing Activities (2020 - 2025)

GoHealth's Cash from Investing Activities history spans 6 years, with the latest figure at -$2.4 million for Q3 2025.

  • For Q3 2025, Cash from Investing Activities fell 117.85% year-over-year to -$2.4 million; the TTM value through Sep 2025 reached -$10.5 million, down 2854.21%, while the annual FY2024 figure was $3.8 million, 127.72% up from the prior year.
  • Cash from Investing Activities for Q3 2025 was -$2.4 million at GoHealth, up from -$2.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $13.3 million in Q3 2024 and bottomed at -$11.4 million in Q3 2021.
  • The 5-year median for Cash from Investing Activities is -$2.8 million (2025), against an average of -$2.7 million.
  • The largest annual shift saw Cash from Investing Activities tumbled 298.66% in 2023 before it skyrocketed 487.6% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$532000.0 in 2021, then crashed by 166.17% to -$1.4 million in 2022, then crashed by 298.66% to -$5.6 million in 2023, then surged by 60.71% to -$2.2 million in 2024, then fell by 6.9% to -$2.4 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Cash from Investing Activities are -$2.4 million (Q3 2025), -$2.8 million (Q2 2025), and -$3.0 million (Q1 2025).